Home
>
US Stocks
>
Olema Pharmaceuticals Inc
Olema Pharmaceuticals Inc
OLMA

Olema Pharmaceuticals Inc (OLMA)

$27.980.72%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$27.43
Today Low/High
$27.18 / $28.12
52 Week Low/High
$19.41 / $60.27
Market Cap
$1.1B

Company Details

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of targeted therapies for women’s cancers. Its lead product candidate, OP-1250, is an oral therapy with combined activity as both a complete estrogen receptor (ER) antagonist, and a selective ER degrader (SERD). OP-1250, both as a monotherapy and in combination with inhibitors of cyclin-dependent kinase4 (CDK4)/6 demonstrated robust tumour shrinkage in several xenograft models, including a breast cancer brain metastasis model.
Organisation
Olema Pharmaceuticals Inc
Employees
37
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Olema Pharmaceuticals Inc (OLMA) share price today?

Can Indians buy Olema Pharmaceuticals Inc (OLMA) shares?

How can I buy Olema Pharmaceuticals Inc (OLMA) shares from India?

Can Fractional shares of Olema Pharmaceuticals Inc (OLMA) be purchased?

What are the documents required to start investing in Olema Pharmaceuticals Inc (OLMA) stocks?

We are a SEBI registered investement advisor